As of 4:02pm ET
| -0.25 / -0.34%|
The 26 analysts offering 12-month price forecasts for Novartis AG have a median target of 88.87, with a high estimate of 101.79 and a low estimate of 73.11. The median estimate represents a +20.13% increase from the last price of 73.98.
The current consensus among 29 polled investment analysts is to Buy stock in Novartis AG. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.